$STZ

Is Constellation Brands Inc (STZ) Undervalued at $115.67 After Q

Constellation Brands (STZ) reported Q2 2027 EPS of $3.32, missing estimates but up 3% YoY. Net sales rose 6% to $2.63B, with beer up 5% and wine/spirits up 17%. Operating income fell 8% due to higher costs. GuruFocus values STZ at $179.42, suggesting 35.5% undervaluation, but notes balance sheet vulnerabilities.

Original reporting
Published Oct 6, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STZ
Bearish
high confidence
Mentioned
$STZ
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$STZBearishMed
01

Why it matters

The earnings miss highlights margin pressure from higher marketing spend, while revenue growth remains solid.

02

Market read

The earnings release provides fresh data that can influence short‑term trading decisions for STZ and peers in the beverage sector.

03

What to watch

Strong wine and spirits growth and solid cash flow could support the stock despite the earnings miss.

Relevance 7/10Novelty 8/10Timing: after-hours release on Oct 6

Background

Constellation Brands is a leading U.S. producer of beer, wine, and spirits, recently filing its Q2 FY2027 8‑K.

Company-level read

Ticker impact

$STZBearishHigh confidence
Context

Constellation Brands reported Q2 FY2027 EPS of $3.32, missing estimates and showing lower operating income.

Expected impact

likely downside as market prices in the EPS miss and margin compression

Evidence & confidence

The miss versus $3.61 consensus and an 8% drop in operating income are material deviations that typically weigh on the stock.

Market effects

May pressure other alcoholic beverage stocks as margin concerns spread.

U.S. consumer discretionary sector could see slight pullback.

Limited; primarily U.S. equity impact.

Counterpoint

Valuation still appears deep‑discounted to fair value, suggesting a potential rebound if the market overreacts.

Key entities

  • Nicholas Fink

    President & CEO who commented on cash flow and capital allocation.

Related articles

$STZHigh

STZ Stock Falls As Modelo And Corona Lose Volume, Full-Year Profit Outlook Holds

Constellation Brands (STZ) reaffirmed its fiscal 2027 earnings guidance of $11.20 to $11.90 per share, with organic net sales and beer net sales expected to range from -1% to +1%. The company also announced the acquisition of SpikedAde for $75 million, with potential earnouts up to $278 million. STZ stock has fallen 16% year-to-date, despite positive retail sentiment on Stocktwits.

$STZMedAI 8/10

Constellation Brands (STZ) Q2 Beats Estimates but Full-Year EPS

Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63B revenue, beating estimates. The company lowered full-year EPS guidance to $11.20-$11.90, below market expectations. STZ offers a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year growth. GuruFocus rates STZ undervalued with a GF Score of 59/100, noting strong profitability but weak momentum. Institutional investors show cautious sentiment.

$STZMedAI 8/10

Constellation Brands buys RTD start-up SpikedAde

Constellation Brands acquired a 100% stake in SpikedAde, a vodka-based RTD brand, for $75m, with up to $278m in performance-based payments. SpikedAde, founded in 2024, has a presence in the eastern US. Constellation plans to expand its distribution using its marketing and sales capabilities.